(Q37103768)

18 August 2017

VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value (English)

1 reference

18 August 2017

1 reference

Ayhan Dirim

1

1 reference

18 August 2017

Asuman Nihan Haberal

2

1 reference

18 August 2017

Mehmet Resit Goren

3

1 reference

18 August 2017

Mehmet Ilteris Tekin

4

1 reference

18 August 2017

Levent Peskircioglu

5

1 reference

18 August 2017

Beyhan Demirhan

6

1 reference

18 August 2017

Hakan Ozkardes

7

1 reference

18 August 2017

7 March 2008

1 reference

International Urology and Nephrology

18 August 2017

1 reference

18 August 2017

40

1 reference

18 August 2017

4

1 reference

18 August 2017

861-868

1 reference

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

18 August 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11255-008-9362-7

Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11255-008-9362-7

Role of cyclooxygenases in angiogenesis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11255-008-9362-7

Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis.

21 January 2018

1 reference

12 December 2020

The Heidelberg classification of renal cell tumours.

1 reference

12 December 2020

Significance of COX-2 expression in human renal cell carcinoma cell lines

1 reference

12 December 2020

Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implications

1 reference

12 December 2020

Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival

1 reference

12 December 2020

Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma

1 reference

12 December 2020

Prognostic significance of morphologic parameters in renal cell carcinoma.

1 reference

12 December 2020

Vascular endothelial growth factor as prognostic factor in renal cell carcinoma

1 reference

12 December 2020

Proliferating cell nuclear antigen: a new prognostic indicator in renal cell carcinoma

1 reference

12 December 2020

Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form

1 reference

12 December 2020

Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma

1 reference

12 December 2020

The puzzle of PCNA's many partners

1 reference

12 December 2020

Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers

1 reference

12 December 2020

Expression of vascular endothelial growth factor protein in human renal cell carcinoma

1 reference

12 December 2020

Vascular endothelial growth factor expression is increased in renal cell carcinoma

1 reference

12 December 2020

Study of cyclooxygenase-2 in renal cell carcinoma.

1 reference

12 December 2020

Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma

1 reference

12 December 2020

CD44s, E-cadherin and PCNA as markers for progression in renal cell carcinoma

1 reference

12 December 2020

Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia

1 reference

12 December 2020

Prognostic factors of renal cell carcinoma: a multivariate analysis

1 reference

12 December 2020

Cyclooxygenase-2 expression and relationship to tumour progression in human renal cell carcinoma

1 reference

12 December 2020

Histopathologic prognostic indicators for renal cell carcinoma

1 reference

12 December 2020

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

1 reference

12 December 2020

Yes, but do they still get headaches?

1 reference

12 December 2020

Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma

1 reference

12 December 2020

Molecular pathology of cyclooxygenase-2 in neoplasia.

1 reference

12 December 2020

Transgenic mouse models in angiogenesis and cardiovascular disease

1 reference

12 December 2020

VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma

1 reference

12 December 2020

VEGF is required for growth and survival in neonatal mice

1 reference

12 December 2020

Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma

1 reference

12 December 2020

Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival

1 reference

12 December 2020

10.1007/S11255-008-9362-7

Identifiers

DOI

1 reference

18 August 2017

1 reference